These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25355999)

  • 1. Immunologic study and optimization of Salmonella delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model.
    Hur J; Byeon H; Lee JH
    Can J Vet Res; 2014 Oct; 78(4):297-303. PubMed ID: 25355999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an attenuated Salmonella-delivery strains expressing adhesin and toxin antigens for progressive atrophic rhinitis, and evaluation of its immune responses in a murine model.
    Byeon H; Hur J; Kim BR; Lee JH
    Vaccine; 2014 Sep; 32(39):5057-64. PubMed ID: 25045826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
    Rajeev S; Nair RV; Kania SA; Bemis DA
    Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
    Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
    PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
    Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
    Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
    Seo J; Pyo H; Lee S; Lee J; Kim T
    Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
    Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
    Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vaccination of sows with Bordetella-Pasteurella vaccines on the occurrence of atrophic rhinitis among their offspring after experimental infection with Bordetella bronchiseptica and toxigenic Pasteurella multocida.
    Barfod K; Pedersen KB
    Nord Vet Med; 1984; 36(11):337-45. PubMed ID: 6531207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on the incidence of atrophic rhinitis of vaccination of sows with a vaccine containing Pasteurella multocida toxin.
    Pedersen KB; Barfod K
    Nord Vet Med; 1982; 34(7-9):293-302. PubMed ID: 7177813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
    Rutter JM
    Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vaccines for atrophic rhinitis--a comparison of three challenge models.
    Magyar T; King VL; Kovács F
    Vaccine; 2002 Mar; 20(13-14):1797-802. PubMed ID: 11906767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
    Sakano T; Okada M; Taneda A; Mukai T; Sato S
    J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophic rhinitis vaccine composition triggers different serological profiles that do not correlate with protection.
    Magyar T; Donkó T; Kovács F
    Acta Vet Hung; 2008 Mar; 56(1):27-40. PubMed ID: 18401954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies.
    Foged NT; Nielsen JP; Jorsal SE
    Vet Rec; 1989 Jul; 125(1):7-11. PubMed ID: 2528856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.
    Petersen SK; Foged NT; Bording A; Nielsen JP; Riemann HK; Frandsen PL
    Infect Immun; 1991 Apr; 59(4):1387-93. PubMed ID: 1706320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
    Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
    J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine.
    Zhang J; Wang M; Zhou N; Shen Y; Li Y
    Vaccine; 2018 Jul; 36(30):4477-4484. PubMed ID: 29909135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.